However, ONC201 only inhibited tumor development in xenograft tumors derived from NB cells with amplified MYCN; this inhibition correlated with a substantial reduction in MYCN protein levels and the reactivation of ATRX expression. The gene discussed is MYCN; the disease is neuroblastoma.